Author

Alex Quin

University of Bristol

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Aaron R. GoldmaniD· 1 shared Aijun Lin· 1 shared Alex Ap. Rosini SilvaiD· 1 shared Beth Hoare· 1 shared Ester Cerdeira SabinoiD· 1 shared Fabio Eudes LealiD· 1 shared Felipe Custodio Carvalho dos Santos· 1 shared Guilherme Lucchesi D Angelo Braz· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Aaron R. GoldmanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

FDXR Upregulation by p63/p73 is a Prognostic and Therapeutic Marker of HTLV-1-Associated Adult T Cell Leukemia/Lymphoma

Lara Gallucci, Maria Josephine, Yasunori Kogure, Alex Ap. Rosini Silva, Vincent Cantaloube-Ferrieu, Marcos Eduardo Souza Abreu, Trusha Ramteke, Phoebe Kibble, Guilherme Lucchesi D Angelo Braz, Rubens de Assis Santos Sebastiao, Luiza Amoroso Lambaz, Aijun Lin, Beth Hoare, Felipe Custodio Carvalho dos Santos, Sophie Shackley, , Iart Luca Shytaj

This study identifies FDXR upregulation as a prognostic marker and therapeutic target in HTLV-1-associated ATL, showing its link to disease severity and sensitivity to fluorouracil.

bioRxiv · Feb 25, 2026 · PreprintMicrobiology